China SMid Insurance: Reviving Life Sales Underpin More Upside, Double Upgrade China Taiping to OW
Summaries are public. PDF access requires an active membership; all members have the same access. Sign in
JPMorgan highlights that China's small- and mid-cap insurers delivered a 58% average return in 2025, outperforming the Hang Seng Index's 28%. Despite this rally, consensus earnings and dividend revisions only partially reflect the favorable macro tailwinds from the second half of 2025. The firm argues that fundamental upside remains robust, driven by underwriting resilience, EPS growth, and dividend visibility.
Consequently, JPMorgan double-upgrades China Taiping (966 HK) from Underweight to Overweight with a December 2026 target price of HK$30.00, offering 44% upside from the current price of HK$20.84. This bullish stance is supported by a faster-than-expected life sales recovery and potential consensus earnings upgrades. Furthermore, China Taiping's industry-leading policy persistence and high participation in dividend insurance products should rapidly reduce liability costs.
Conversely, the firm downgrades China Reinsurance (1508 HK) from Overweight to Neutral with a HK$1.80 target price, citing softening reinsurance pricing. Guy Carpenter's global property line index dropped 12% year-over-year in January 2026, marking the steepest decline in a decade. This deterioration pressures non-life underwriting profitability. The preference order stands as China Taiping, ZhongAn Online, China Reinsurance, and Sunshine Insurance.